Find our deprescribing.org Shared-Decision Making tools to help collaboratively identify potential medication-related adverse effects here:
buff.ly/XonvJAA
Find our deprescribing.org Shared-Decision Making tools to help collaboratively identify potential medication-related adverse effects here:
buff.ly/XonvJAA
💡 "Anticholinergic Burden" refers to the cumulative anticholinergic effect of all medications taken by an individual.
A helpful systematic review has compiled available anticholinergic burden scales, comparing them based on factors such as included medications & scoring systems:
buff.ly/ExUaJoT
It's not too late to register for the 4th Annual Focus on Geriatric Pharmacotherapy Virtual Conference, happening this week on March 4th! 🗓
Get updates on our new statin deprescribing guidelines, along with other exciting topics in geriatric medicine!
Register now:
lnkd.in/eSiF9vJV
This work is highly complementary to our deprescribing.org #antihyperglycemia #deprescribing resources which can be found here:
buff.ly/FXQJOJn
Read about our DIAL study to reduce diabetes overtreatment here!
buff.ly/MOJMvfk
A recent RCT published in @jamanetworkopen.com finds #pharmacist-led outreach guided by an evidence-based hypoglycemia-prevention algorithm was more likely to lead to safer diabetes prescribing compared to a control group.
Read the full study here:
buff.ly/0uBaX11
The OPERAM Trial was a multi-country RCT investigating the effects of hospital pharmacotherapy optimization on drug-related hospital admissions in multimorbid, older adults with polypharmacy.
A longitudinal secondary analysis of the trial revealed many interesting findings:
buff.ly/9hehjjb
It was a great talk indeed! Thanks for having us, @nhp-uoft.bsky.social
Learn more about our DIAL study here:
lnkd.in/gxncjf2a
Our antihyperglycemic #deprescribing tools can be found here:
lnkd.in/ggwJhCCy
Our resources for Shared-Decision Making to improve communication between patients, care partners and prescribers can be found here:
deprescribing.org/resources/de...
Great to see deprescribing.org mentioned throughout the article as a leading organization in the deprescribing movement. Find our resources to guide appropriate deprescribing (including our new #statin deprescribing resources) here:
deprescribing.org/resources/de...
A review of 31 medico-legal cases involving #deprescribing across Canada 🇨🇦 highlights that we still have much to learn on how to improve deprescribing practices in primary care in older adults:
link.springer.com/article/10.1...
@cmpa-acpm.ca
@springernature.com
Could Artificial Intelligence (AI) help or harm efforts to reduce low-value tests and treatments?
📅 Join @choosingwiselyca.bsky.social on Feb 12, 2026 at 12:00 pm ET to learn more about the role of AI in addressing overuse in healthcare.
👇 Register here:
buff.ly/EGfXzmx
Check out a Virtual Seminar on "Resetting the DIAL on diabetes management in long-term care homes" on Tuesday, February 17 from 12:00 to 1:00 p.m. ET with @lisamccarthy.bsky.social & @ilianalega.bsky.social
⛓️💥 Register here: buff.ly/bP3POSt
Find deprescribing.org resources to help reduce potentially inappropriate medication use here:
buff.ly/NgSVLPm
A Clinical Trial published in @jama.com finds Electronic Health Record (EHR) prompts informed by behavioural-science can significantly increase the rates of #deprescribing of potentially inappropriate medications used by older adults:
buff.ly/uF489QP
"Reduction of the overuse of PPIs should be based on lack of indication for long-term use or lack of indication for one in the first place".
Our PPI deprescribing guidelines and algorithm can help identify if a valid indication exists for a PPI. Find those resources and more here:
buff.ly/9H1hLqw
Great editorial in @bmj.com written by our deprescribing.org Co-Director Wade Thompson, along with Anton Pottegård!
buff.ly/DfygbLS
While PPI use without an indication is a recognized problem, we should also avoid using low-quality evidence to justify #deprescribing decisions.
#Deprescribing should always be done in collaboration with a healthcare professional.
Check out our Shared-Decision Making resources to learn how collaboration between the patient, care partners, and healthcare providers lead to better deprescribing decisions:
deprescribing.org/resources/de...
Out of those with dementia, a significant portion suffer from inappropriate #polypharmacy, putting older adults at risk of medication-related side effects.
Visit deprescribing.org to find resources on how to #deprescribe these medications safely:
deprescribing.org/resources/de...
January is Alzheimer's Awareness Month in Canada!
By 2030, researchers project that nearly 1 million people in Canada could be living with dementia.
No one should face dementia alone.
Learn more about dementia and how you can help at:
alzheimer.ca/en
#ForgetNoOne
Find our #deprescribing guidelines, algorithms, and other resources to review potentially inappropriate CNS-active drugs (such as benzodiazepines, Z-drugs, and antipsychotics) here:
buff.ly/9H1hLqw
New research letter published in @jama.com showed an encouraging decline in potentially inappropriate CNS-active prescriptions from 2013 to 2021 in United States Medicare data. 📉
buff.ly/OgmSJbr
However, more work still needs to be done to further reduce the use of CNS-active PIMs.
Register to the next Int'l Deprescribing Journal Club on Feb 26!
Hosted by the Portuguese Deprescribing Network, Dr. Teixeira Rodrigues presents the design & implementation of C-SENIoR, an interprofessional (GP & pharm) deprescribing model to optimise PPI use in older adults.
tinyurl.com/bdhh5kpp
Find our @deprescribing.bsky.social Shared Decision-Making tools here to help encourage collaborative deprescribing decision-making:
buff.ly/zwrJllS
Recent survey study from @journalgim.bsky.social finds low concordance between patients & their GPs with regard to identifying PIMs for #deprescribing.
Explicit discussions considering both patient & GP perspectives are needed for deprescribing success!
Read the full article here:
buff.ly/deJXgyT
Find this guideline along with other helpful #deprescribing guidelines (both completed or in-development) on DEPOT here:
buff.ly/EoTxgTw
Find our complementary deprescribing.org BZRA deprescribing tools (e.g. algorithm, patient pamphlet, infographic, and whiteboard video) here:
buff.ly/dToyrDV
🔍 Check out the latest addition to our Deprescribing Guidelines Repository (DEPOT)!
"The Joint Clinical Practice Guideline on Benzodiazepine Tapering" from the American Society of Addiction Medicine provides comprehensive benzodiazepine tapering guidance.
Read more here:
buff.ly/TJOQUBw
🌍 Antihypertensives are among the commonly prescribed medications globally.
Read about a recently-published systematic review & meta-analysis on #deprescribing antihypertensive medications in older people, conducted together with our collaborators here:
buff.ly/CPznF05
Read about the thoughts of key global deprescribing stakeholders from the 2024 Australian Deprescribing Network Meeting regarding:
💡 The current landscape of #deprescribing research and practice
‼️ The top future priorities for deprescribing
👉 buff.ly/8e2MMZp
@deprescribeau.bsky.social
Merry Christmas and Happy Holidays to all from deprescribing.org! ✨
Wishing everyone a safe and joyous holiday season! ❤️
May your holidays be focused on what truly matters - sometimes "less is more" both with prescriptions and with life!